Riskpilot← Back to searchSign inGet full access12Konsult AB
ABActiveOrg 5568634363Kastanjegatan 2Other human health activities n.e.c. · NACE 8699Est. 20110 employees
Revenue 2025
SEK 359K
EBITDA margin
0.3%
+100% vs 2024
Equity ratio
-561.4%
Financial strength
Net profit 2025
SEK 328
+100% vs 2024
| Revenue | SEK 359K | — |
| EBITDA | SEK 1K | +100% |
| Net profit | SEK 328 | +100% |
| Total assets | SEK 22K | -55% |
| Equity | SEK -121K | +0% |
| Employees | 0 | — |
Legal name
12Konsult AB
Org number
5568634363
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
5 september 2011
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva utbildning, behandling och handledning inom beroendeproblematik och psykosociala förhållanden och sammanhang ävensom idka därmed förenlig verksamhet.
Address
Kastanjegatan 2
Phone
+46708505783
Email
jenswallman@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 661 | 0 | 0 | 0 | 359 |
| Staff expenses | — | — | — | — | −15 |
| EBITDA | −279 | −528 | −313 | −213 | 1 |
| Depreciation & amort. | −72 | −49 | −8 | −0 | — |
| EBIT | −351 | −577 | −321 | −213 | 1 |
| Net financials | — | −200 | −158 | 42 | −1 |
| Profit before tax | −178 | −277 | −399 | −171 | 0 |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | −178 | −277 | −399 | −171 | 0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 763 | 450 | 336 | 48 | 22 |
| Equity | 329 | 51 | 50 | −121 | −121 |
| Long-term debt | 375 | 337 | 241 | 118 | 90 |
| Short-term debt | 59 | 62 | 45 | 52 | 53 |
| Total debt | 434 | 399 | 286 | 170 | 143 |
EBITDA margin
0.3%
This company
15.8%
Market median
-98% vs market
20212025
Equity ratio
-561.4%
This company
38.2%
Market median
-1570% vs market
20212025
Return on equity
32800.0%
This company
18.4%
Market median
+178161% vs market
20212025
Net profit margin
0.1%
This company
8.1%
Market median
-99% vs market
20212025
Asset turnover
16.66×
This company
1.12×
Market median
+1387% vs market
20212025
Debt / equity
1.18×
This company
0.62×
Market median
-90% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
MO Audit | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mareandrum AB
12Konsult AB Board members of 12Konsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Miralem Omerovic | Audit | 0 companies |
| Jens Erik Wallman | Board of Directors | 0 companies |
| Eric Oscar Nils Wallman | Deputy Board Member | 0 companies |